Company: HCTI
Filing Date: 2025-02-25
Form Type: PRE 14A
Source: 0001213900-25-017146
Chunk: 19

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-25
Form: PRE 14A
Chunk 19
---
 the applicable rules of the Nasdaq. Each member of the audit
committee meets the requirements for financial literacy under the applicable rules and regulations of the SEC and the Nasdaq. The Board
has designated Mr. McClurg as an “audit committee financial expert,” as defined under the applicable rules of the SEC. The
audit committee operates under a written charter adopted by the Board.

<div align='center'>11</div>

The audit committee’s general role is to
assist the Board in monitoring our financial reporting process and related matters. Its specific responsibilities are set forth in its
charter.

The audit committee has reviewed the Company’s
consolidated financial statements for 2023 and met with management, as well as with representatives of M&K CPAS, PLLC, the Company’s
independent registered public accounting firm, to discuss the financial statements. The audit committee also discussed with members of
M&K CPAS, PLLC the matters required to be discussed by the Auditing Standard No. 1301, “Communication with Audit Committees,”
as adopted by the Public Company Accounting Oversight Board.

In addition, the audit committee received the
written disclosures and the letter from M&K CPAS, PLLC required by applicable requirements of the Public Company Accounting Oversight
Board regarding the independent accountant’s communications with the audit committee concerning independence and discussed with
members of M&K CPAS, PLLC its independence.

Based on these discussions, the financial statement
review, and other matters it deemed relevant, the audit committee recommended to the Board that the Company’s audited consolidated
financial statements for 2023 be included in its Annual Report on Form 10-K for 2023.

The information contained in this audit committee
report shall not be deemed to be “soliciting material,” “filed” or incorporated by reference into any past or
future filing under the Securities Exchange Act of 1934 or the Securities Act of 1933 unless and only to the extent that the Company
specifically incorporates it by reference.

Signed by the Audit Committee:

Ronald McClurg (Chairperson)

Jainal Bhuiyan

Dave Rosa

Compensation Committee

The members of the compensation committee are
Dave Rosa, and Ronald McClurg. Mr. Rosa is the Chair of the compensation committee. Our Board of Directors has determined that
each of the members of the compensation committee is “independent” within the meaning of the rules of the Nasdaq. Our compensation
committee assists our Board of Directors in the